FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval

August 10, 2016 12:50 PM EDT
Get Alerts HRTX Hot Sheet
Trade HRTX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Below is the FDA's approval letter Heron Therapeutics' (Nasdaq: HRTX) SUSTOL:

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Insiders' Blog

Add Your Comment